Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...
Green Matters on MSN1d
What You Need to Know About the Depo-Provera Lawsuits Being Filed Against PfizerForbes ADVISOR says anyone with questions about their well-being after prolonged use of Depo-Provera should reach out to ...
NEW YORK (AP) — A mural honoring ancient and modern figures in medicine that has hung in the lobby of Pfizer’s original New ...
Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock ...
Zacks.com on MSN10h
Pfizer (PFE) Upgraded to Buy: What Does It Mean for the Stock?Pfizer (PFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...
KP.2-adapted COVID-19 vaccine received FDA approval. Manufacturing Optimization Program aims to deliver $1.5b in savings by ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme ...
HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC ...
Pfizer is joining Eli Lilly in making certain of its prescription drugs available directly to consumers, a trend that worries ...
Pfizer Inc. (NYSE: PFE) continues to showcase potential practice-changing research and next-generation candidates across its robust Oncology portfolio at the European Society for Medical Oncology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback